Novartis is reported to be developing new blood pressure tablets with Proteus Biomedical, where small chips are implanted within. These microchips will communicate with a shoulder-worn sensor, and they are currently undergoing a small clinical trial to test whether this method is suitable to track and improve drug regiment compliance. So far, compliance within the trial has improved by leaps and bounds, touching 80% from a lowly 30% initially. Having your pill nag you – that’s something new, eh.
Filed in . Read more about Tablet.